CHANGING LANDSCAPE OF VIRAL SAFETY –
EXISTING AND ADVANCED TECHNOLOGIES

This global meeting is organized in close collaboration with an excellent Scientific Program Planning Committee including European and U.S. FDA regulators, industry experts, supplier specialists, and dedicated PDA Europe support.
The overall program is designed to provide an update on regulatory expectations and the scientific framework around the virus safety of plasma-derived and biotechnology medicinal products, as well as particularly innovative cell- and gene therapies.
Similar to earlier events in this long-standing series, current and newly emerging viral threats, viral safety considerations around the selection of low-risk starting materials, virus detection, and identification methods and strategies, and the design and validation of virus inactivation and removal processes will be key topics for discussion. In addition, intensified continuous manufacturing processes and their potential impact on facility design and viral safety will also be considered.

We look forward to seeing you at Booth # 10!